Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $154.9800 (1.85%) ($153.4400 - $155.6400) on Fri. Nov. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.62% (three month average) | RSI | 73 | Latest Price | $154.9800(1.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.6% a day on average for past five trading days. | Weekly Trend | ABBV advances 2.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(15%) XBI(14%) DIA(12%) SPLV(12%) XLP(12%) | Factors Impacting ABBV price | ABBV will decline at least -0.81% in a week (0% probabilities). VIXM(-11%) UUP(-8%) TBT(-4%) JETS(-4%) IWN(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.81% (StdDev 1.62%) | Hourly BBV | 1 () | Intraday Trend | 0.5% | | | |
|
5 Day Moving Average | $152.76(1.45%) | 10 Day Moving Average | $150.92(2.69%) | 20 Day Moving Average | $149.55(3.63%) | To recent high | 0% | To recent low | 15.5% | Market Cap | $273.429b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |